在视网膜动脉阻塞中使用抗血栓剂:叙述性综述
Wan-Yu Liu1, Yun-Hsin Tang2,3, Yi-Hsing Chen3,4
1Department of Medical Education, Chang Gung Memorial Hospital, Linkou Main Branch, Taoyuan, Taiwan.
The Kaohsiung journal of medical sciences
|January 16, 2025
概括
抗凝固剂和抗血小板疗法在治疗视网膜动脉封闭 (RAO) 方面表现有前途,通过预防血栓形成. 需要进一步的研究来确定最佳的使用和安全性,以改善视觉结果.
科学领域:
- 眼科医生 眼科 眼科
- 血管医学 血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 视网膜动脉封闭 (RAO) 是一种眼科紧急情况,导致严重的视力丧失.
- 目前的治疗重点是恢复血液流动,但正在探索抗血栓治疗方法.
研究的目的:
- 审查RAO抗凝剂和抗血小板治疗的疗效和安全性.
- 检查这些治疗的机制和潜在益处.
- 发现当前研究中的差距,并指导未来的研究.
主要方法:
- 目前研究和临床试验的文献综述.
- 对抗凝血剂 (如肝素,DOACs) 和抗血小板剂 (如阿司匹林) 的分析.
- 机制的评估,有效性,安全性和争议.
主要成果:
- 抗血栓剂可以防止血栓的扩散和血小板聚合.
- 这些疗法可以促进微血管循环,减轻缺血性损伤.
- 由于出血风险,最佳使用,时间和持续时间仍然是争论的主题.
结论:
- 抗血栓治疗是一种潜在的RAO的辅助治疗方法.
- 需要基于证据的指导方针,需要大规模的前性研究.
- 在患者管理中,平衡抗出血并发症的疗效至关重要.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...


